Published on 10 Dec 2024 on Benzinga · via Yahoo Finance
Arvinas-Pfizer Partner Cancer Drug Trial Shows 63% Clinical Benefit In Breast...
On Tuesday, Arvinas Inc. (NASDAQ:ARVN) and Pfizer Inc. (NYSE:PFE) announced preliminary data from...
Want to become a better investor?
Start tracking your investments with Statfolio
Sign up for free